Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Me-4FDG PET for Early Diagnosis of Lung Cancer
NCT05558904Phase 2Recruiting
- Sponsor
- UCLA Jonsson Comprehensive Cancer Center
- Start
- Jan 2023
- Primary completion
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of alpha-methyl-4-deoxy-4-[(18)F]fluoro-D-glucopyranoside in lung adenocarcinoma, sponsored by UCLA Jonsson Comprehensive Cancer Center. Started Jan 2023; status: recruiting.
02
Drugs
alpha-methyl-4-deoxy-4-[(18)F]fluoro-D-glucopyranoside
03
Conditions
lung adenocarcinoma
Beyond the preview
Go deeper on NCT05558904.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05558904.